Abstract #3935

MEMRI-guided preclinical trial of an experimental TAM-targeted therapy in mouse medulloblastoma

Hari Rallapalli¹, I-Li Tan², Alexandre Wojcinski², Alexandra L Joyner², and Daniel H Turnbull¹

¹New York University School of Medicine, New York, NY, United States, ²Sloan Kettering Institute, New York, NY, United States

Using our high-throughput MEMRI pipeline, presented previously, we tested an experimental anticancer drug in mouse models of sporadic medulloblastoma.

This abstract and the presentation materials are available to members only; a login is required.

Join Here